| 000 | 02831nam a2200601 i 4500 | ||
|---|---|---|---|
| 005 | 20250919085947.0 | ||
| 006 | m e d | ||
| 007 | cr bn |||m|||a | ||
| 008 | 170131s2011 enka ob 001 0 eng d | ||
| 020 | _a9781780840246 (PDF) | ||
| 020 | _a9781780840253 (ePub) | ||
| 020 | _z9781780841120 (print) | ||
| 040 |
_dUKM _erda |
||
| 090 | _aebook PHCTM | ||
| 245 | 0 | 0 |
_aAddressing unmet medical needs in relapsing-remitting multiple sclerosis / _ceditors Richard A. Rudick, Robert A. Bermel. |
| 264 | 4 |
_aLondon : _bFuture Medicine Ltd , _c[2011],©2011. |
|
| 300 |
_a1 electronic text (77 pages) : _bdigital file. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 490 | 1 |
_aThe Future Science Group eBook collection, _x2047-332X |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aAddressing unmet medical needs in RR-MS / Robert A. Bermel & Richard A. Rudick -- Current guidelines and standard treatments of RR-MS / R. Philip Kinkel & Augusto Miravalle -- Oral agents for the treatment of RR-MS / Douglas R. Jeffery -- Monoclonal antibodies / Jennifer Graves & Emmanuelle L. Waubant -- Other therapeutics in the pipeline and future directions / Yuval Karmon, Bijal K. Mehta & Bianca Weinstock-Guttman. | |
| 506 | _aRestricted to subscribers or individual electronic text purchasers. | ||
| 530 | _aAlso available in print. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 538 | _aSystem requirements: Adobe Acrobat Reader. | ||
| 588 | _aTitle from PDF title page (Future Medicine eBooks Web site, viewed December 13, 2011). | ||
| 650 | 0 |
_aMultiple Sclerosis _xtreatment. |
|
| 650 | 0 |
_aInterferon _xTherapeutic use. |
|
| 650 | 0 |
_aPeptides _xtherapeutic use. |
|
| 650 | 0 |
_aMonoclonal antibodies _xTherapeutic use. |
|
| 650 | 0 |
_aAntineoplastic Agents _xtherapeutic use. |
|
| 650 | 1 | 2 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy. |
| 650 | 1 | 2 |
_aInterferon-beta _xtherapeutic use. |
| 650 | 1 | 2 |
_aPeptides _xtherapeutic use. |
| 650 | 1 | 2 |
_aAntibodies, Monoclonal _xTherapeutic use. |
| 650 | 1 | 2 |
_aAntineoplastic Agents _xtherapeutic use. |
| 655 | 0 | _aElectronic books. | |
| 700 | 1 |
_aRudick, Richard A., _eeditor. |
|
| 700 | 1 |
_aBermel, Robert A., _eeditor. |
|
| 710 | 2 | _aFuture Medicine Ltd. | |
| 773 | 0 | _aFuture Medicine | |
| 776 | 0 | 8 |
_iPrint version: _z9781780841120 |
| 830 | 0 |
_aFuture Science Group eBook collection, _x2047-332X. |
|
| 856 | 4 | 0 | _uhttps://www-futuremedicine-com.eresourcesptsl.ukm.remotexs.co/doi/epdf/10.2217/9781780840246 |
| 856 | 4 | 0 | _uhttps://doi.org/10.2217/9781780840246 |
| 907 |
_a.b1642332x _b2023-06-09 _c2019-11-12 |
||
| 942 |
_n0 _kebook PHCTM |
||
| 914 | _avtls003616526 | ||
| 998 |
_ah _b2017-05-01 _cm _dz _feng _genk _y0 _z.b1642332x |
||
| 999 |
_c615597 _d615597 |
||